Transcutaneous Repetitive Phrenic Nerve Stimulation in Healthy Adults
1 other identifier
observational
12
1 country
1
Brief Summary
The goal of this observational study is to characterize the standardized stimulation parameter for noninvasive, transcutaneous, repetitive phrenic nerve electrical stimulation. The main questions it aims to answer are:
- Is the phrenic nerve repetitive electrical stimulation test feasible for use as non-invasive transcutaneous electrical stimulation?
- What is the most optimal stimulation parameters for repetitive phrenic nerve electrical stimulation in healthy adult populations in terms of effective and safe activation of diaphragm?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2023
CompletedStudy Start
First participant enrolled
April 17, 2023
CompletedFirst Posted
Study publicly available on registry
May 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2023
CompletedMarch 12, 2024
March 1, 2024
3 months
March 23, 2023
March 9, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Phrenic nerve compound muscle action potential (CMAP) amplitude (mV)
∙ CMAP Amplitude (mV)
Baseline
∙ Phrenic nerve compound muscle action potential (CMAP) duration (ms)
∙ CMAP duration (ms)
Baseline
∙ Phrenic nerve compound muscle action potential (CMAP) area (mV∙ms)
∙ CMAP area (mV∙ms)
Baseline
Secondary Outcomes (4)
Respiratory function
Baseline
Diaphragmatic function
Baseline
Diaphragmatic function
Baseline
Pain during phrenic stimulation
Baseline
Interventions
Phrenic nerve electrical stimulation with different stimulation intensity and frequency
Eligibility Criteria
Healthy adult population who have read the recruitment announcement, voluntarily expressed their intention to participate, and have met the eligibility criteria.
You may qualify if:
- Koreans who speak Korean as their mother tongue, aged 19 or older and younger than 40.
- Those who understood the purpose and procedure of this study and voluntarily participated with consent.
You may not qualify if:
- \- Those who have any neuromuscular disease.
- \- Those whom abnormal findings are observed on a neurological examination. e.g.) Cases with abnormal findings in peripheral motor nerve (median nerve) and sensory nerve (sural nerve) conduction studies performed in screening.
- e.g.) People who have been diagnosed with a neuromuscular junctional diseases such as myasthenia gravis or receiving related treatment.
- In the case of implantable electronic medical devices such as pacemakers, implantable cardioverter defibrillators (ICDs), and spinal cord stimulation devices.
- Those who have any history of radiation therapy or chemotherapy for cancer within a year.
- People who have a history of cardiovascular or cerebrovascular disease or lung disease within 6 months.
- Those who have been diagnosed with a psychiatric/neurological problem or taking related medications that may affect electrophysiological study.
- Those who are pregnant or may be pregnant.
- Those who are judged to lack the cognitive ability to understand the explanation of the purpose and procedure of this study.
- Those whom the researchers judge for other reasons to be inappropriate to participate in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 03080, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Sung Eun Hyun, MD, PhD
Seoul National University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor (MD, PhD)
Study Record Dates
First Submitted
March 23, 2023
First Posted
May 30, 2023
Study Start
April 17, 2023
Primary Completion
July 18, 2023
Study Completion
July 18, 2023
Last Updated
March 12, 2024
Record last verified: 2024-03